Recent Advancements in the Application of Circulating Tumor DNA as Biomarkers for Early Detection of Cancers
ACS Biomaterials Science & Engineering · 12.08.2024 · 10 (8) · 4740-4756
DOI: 10.1021/acsbiomaterials.4c00606 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Biomaterials Science & Engineering, online erschienen am 01.07.2024. Verfasst von Mahima Mishra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Amity Institute of Biotechnology, Amity University, Noida 201301, India. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Biomarkers, Tumor, Early Detection of Cancer, Neoplasms. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Early detection of cancer is vital for increasing patient survivability chances. The three major techniques used to diagnose cancers are instrumental examination, tissue biopsy, and tumor biomarker detection. Circulating tumor DNA (ctDNA) has gained much attention in recent years due to advantages over traditional technology, such as high sensitivity, high specificity, and noninvasive nature. Through the mechanism of apoptosis, necrosis, and circulating exosome release in tumor cells, ctDNA can spread throughout the circulatory system and carry modifications such as methylations, mutations, gene rearrangements, and microsatellite instability. Traditional gene-detection technology struggles to achieve real-time, low-cost, and portable ctDNA measurement, whereas electrochemical biosensors offer low cost, high specificity alongside sensitivity, and portability for the detection of ctDNA. Therefore, this review focuses on describing the recent advancements in ctDNA biomarkers for various cancer types and biosensor developments for real-time, noninvasive, and rapid ctDNA detection. Further in the review, ctDNA sensors are also discussed in regards to their selections of probes for receptors based on the electrode surface recognition elements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Amity Institute of Biotechnology, Amity University, Noida 201301, India.
- Department of Physiology, University of Gour Banga, Malda-732103, West Bengal, India.
- Department of Chemistry and Nanoscience, GLA University, Mathura, 281406 Uttar Pradesh, India.
- School of Medicine, University of Leeds, Leeds LS53RL, United Kingdom.
ORCID-Profile: Arindam Pramanik
Zitieren
APA
Mishra, M., Ahmed, R., Das, D. K., Pramanik, D. D., Dash, S. K., & Pramanik, A. (2024). Recent Advancements in the Application of Circulating Tumor DNA as Biomarkers for Early Detection of Cancers. ACS Biomaterials Science & Engineering, 10(8), 4740-4756. https://doi.org/10.1021/acsbiomaterials.4c00606
Vancouver
Mishra M, Ahmed R, Das DK, Pramanik DD, Dash SK, Pramanik A. Recent Advancements in the Application of Circulating Tumor DNA as Biomarkers for Early Detection of Cancers. ACS Biomaterials Science & Engineering. 2024;10(8):4740-4756. doi:10.1021/acsbiomaterials.4c00606
BibTeX
@article{Mishra2024,
author = {Mishra, Mahima and Ahmed, Rubai and Das, Deepak Kumar and Pramanik, Devlina Das and Dash, Sandeep Kumar and Pramanik, Arindam},
title = {Recent Advancements in the Application of Circulating Tumor DNA as Biomarkers for Early Detection of Cancers},
journal = {ACS Biomaterials Science & Engineering},
year = {2024},
volume = {10},
number = {8},
pages = {4740--4756},
doi = {10.1021/acsbiomaterials.4c00606}
}
EUVIMED